TY  - JOUR

T1  - Bisphosphonates' antitumor activity: An unravelled side of a multifaceted drug class

JO  - Bone

PY  - 2011/01/01

AU  - Clézardin P

ED  - 

DO  - DOI: 10.1016/j.bone.2010.07.016

PB  - Elsevier BV

VL  - 48

IS  - 1

SP  - 71

EP  - 79

Y2  - 2025/10/26

ER  -